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The National Institute of Environmental Health Sciences/National Toxicology Program
(NIEHS/NTP) is developing a new interagency initiative in exposure assessment This initiative
involves theNIEHS, the Centers for Disease Control andPrevention through itsNationalCenter
for Environmental Health, the National Institute for Occupational Safety and Health, the EPA,
and other participating institutes and agencies ofthe NTP. This initiative will benefit public
health and priority setting in a number ofways. First, as discuse above, it will strengthen the
scientific foundation for riskassessments bythe delopment ofmore credibleexposure/response
relationships in people by improving cross-species extrapolation, the development ofbiologically
baseddose-responsemodels, andtheidetification ofsensitivesubpopulations andfor"margnof
exposure" based estimates ofrisk Second, it will provide the kind ofinrmation necessary for
decidingwhich chemicals should be studiedwith thelimited resources available for toxicological
testing. Forexample, there are 85,000 chemicals in commerce today, andthe NTP can onlypro-
vide toxicological evaluations on 10-20 per year. Third, we would use the naton obtained
from theexposure initiative to focus our rsearch on mitr that areactuallypresent inpeople's
bodies. Fourth, wewould obtain information on the kinds and amount ofchenicals in children
and other potentially sensitive subpopulations. Dete tions ofwhether additional safety fac-
tors need to be applied to children must rest, in part, upon comparative exposure analyses
between childrenandadults. Fifth, this initiative, taken togetherwith the environmental genome
initiative, will provide the science base essential for mningful studies on gene/environment
interactions, particularly for strengthening the evauation ofepidemiology studies. Sixth, efficacy
ofpublichealth policiesaimed atreducinghumnu exposure tochemical agentscouldbeevaluated
in a more me way ifbody burden data were available over time, induding remediation
aroundSuperfind sites andefiorts to achieveenvironmentaljustce. Theexposure assessment ini-
tiative is neededto addresspublichealth needs. It isfeasiblebecause ofrecentadvances inanalyti-
cal technology and molecaar biology, and it is an example ofhow different agencies can work
together to betterfulfill their respective missions. Key work eposure assessment, gene/environ-
ment mixtues, National Toxicology Program, rskassessment, sensitive subpopulations. Environ
HealhPrsect106:6234627 (1998). [Online2September 1998]
htp://cpnetl.niebs.niA.gov/docs/1998/106p623-6271ucier/abstract.html
The National Toxicology Program (NTP)
was established as a cooperative effort within
the Public Health Service ofthe Department
ofHealth and Human Services (DHHS) to
coordinate toxicology research and testing
activities within the department; to provide
information about potentially toxic chemi-
cals to health regulatory and research agen-
cies, scientificand medical communities, and
thepublic; and to strengthen the science base
in toxicology. In its 20 years, the NTP has
become the world's leader in designing, con-
ducting, and interpreting various types of
assays for toxicity. Through its activities, the
NTP provides, directly or indirectly, a large
component of the basic scientific data that
other federal and state scientific and regula-
tory agencies, as well as private sector organi-
zations, find useful in responding to issues
relevant to the effects ofchemical substances
on human health and the environment.
In order to meet the responsibilities,
NTP strategies and approaches are evolving
along a number of fronts. The overall goal
of these initiatives is to more efficiently
evaluate chemicals for toxic effects using a
broad array oftest systems and to generate
data that strengthen the scientific founda-
tion on which risk assessments are based.
The overarching motivation of the pro-
gram is to use the best science possible in
setting priorities, designing and conduct-
ing studies, and reporting results in an
objective way that best meets the needs of
the public and federal and state health and
regulatory agencies. We believe that studies
which address critical knowledge gaps that
create uncertainty in toxicological evalua-
tions offer the best opportunities for pre-
ventingenvironmentally mediated diseases.
Human studies are an increasingly
important factor in NTP studies, and oppor-
tunities in molecularepidemiology and expo-
sure assessment have produced significant
changes in the NTP (1). The human expo-
sureworkbuilds on the National Health and
Nutrition Examination Surveys (NHANES),
a pioneering federal interagency program in
which the Centers for Disease Control and
Prevention (CDC) laboratories developed
new analytic methods and generated consid-
erable human blood and urine data for
exposure estimation of the U.S. population
(2). The work also builds on another intera-
gency pilot study lead by the EPA, the
National Human Exposure Assessment
Survey (NHEXAS), which is designing an
exposure surveillance system for the U.S. pop-
ulation. This will obtain periodic and system-
atic measurements of human exposures to
multiple chemicals (3). For example, a major
interagency initiative is being developed in
exposure assessment, which is frequently the
weakest link in risk assessments (4). This ini-
tiative, in collaboration with the CDC
National Center for Environmental Health
(CDC-NCEH), the National Institute for
Occupational Safety and Health (NIOSH),
and the EPA, will quantify the body burdens
of chemicals released into the environment
and workplace and will address a number of
public health issues, as discussed later in this
commentary. NTP studies aimed at under-
standing gene/environment interactions will
benefit tremendously from the NIEHS's
Environmental Genome Project, which will
characterize the human variability of hun-
dreds ofenvironmentally relevant genes (5,6).
This information, taken together with the
exposure initiative, wi create new directions
in risk assessment methodologies for the NTP
and should lead to methods for reducing
reliance on default assumptions in risk assess-
ment. Thefollowingsections address the ben-
efits and opportunities to the NTP that
should result from this human exposure
assessment initiative (Fig. 1).
Priority Setting
With limited resources it is necessary to set
priorities for studying the approximately
70,000 chemicals currently in use (7). For
example, the NTP, which is the nation's
largest toxicology program, can initiate
approximately 10 long-term cancer studies
and 10 reproductive studies per year. These
studies are lengthy-each study can take sev-
eral years to complete-and cost millions of
dollars. In order to knowwhere to set priori-
ties for use of limited resources, we need to
know not only which chemicals are found in
the environment, and in occupational expo-
sure circumstances, but what mixtures of
toxic compounds are in humans and at what
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Figure 1. Benefits and opportunities to the NTP and public health should result from improved human
exposure assessment.
levels. In addition, trends over time must be
determined. We need to knowwhetherbody
burdens oflead, polychlorinated biphenyls
(PCBs), dioxins, volatile organics, and other
air and water pollutants are increasing,
remaining at the same levels, ordecreasing as
regulations meant to decrease the levels of
these chemicals in the environment are
designed and implemented. Workers are fre-
quently exposed to higher levels ofmany of
the 85,000 chemicals in use in the United
States than the general public. These chemi-
cals indude benzene, methylene chloride, jet
fuel, herbicides, and pesticides. Frequently,
the only way to determine actual increase in
human body burden is to take blood mea-
surements before and after exposure.
Improving the specificity and sensitivity of
the chemical tests now available for this pur-
pose will allow small blood samples to be
used to generate data ofhigh quality on the
relationship between workplace exposure cir-
cumstances andworker exposure. This infor-
mation is critical in priority setting.
Chemicals found in ahigh proportion ofthe
population or in high amounts in certain
segments ofthe population would be given a
high priority for toxicological and epidemio-
logical studies. Furthermore, the design of
studies will benefit from knowledge ofchem-
ical levels in the general population being
used to select lowdoses for NTP studies that
will be relevant to the real world. Another
example of the benefits of our exposure
assessment initiative is popular dietary sup-
plements. Over 1,000 are currently in use. It
is important to determine which are harmful
and which are safe. They are not subject to
the Food and Drug Administration (FDA)
premarket regulatory authority, so toxicolog-
ical and exposure information is frequently
not available (8). The NTP and the NIH
Office ofDietary Supplements is organizing
aworkshop in September 1998 to set priori-
ties for research on dietary supplements and
to determine which ones should be studied
first (9). Blood measurements of those
dietary supplements in heavy users will pro-
vide valuable body burden data relative to
the general population. Comparisons oflev-
els causing adverse health effects in experi-
mental animals can be compared to body
burdens in people to determine ifthere is or
is notanadequate margin ofsafety.
Another example relates to Europe's ban
on import ofmeats from the United States
because ofthe use ofgrowth-promoting hor-
mones. Data showing increased levels of
growth-promoting hormones in human
blood, ifan increase actually occurs, would
be ofcritical importance for health and eco-
nomic reasons. Ifthere is little or no increase
in thesecompounds in thehuman bodybur-
den as determined by blood or urine mea-
surements, then it would be unlikely that
eating meat from growth-promoted animals
could cause deleterious health consequences.
Ifthere are elevations ofthese compounds in
blood or urine, the biological meaningofthe
increases would then have to be determined
bytoxicologyandepidemiologystudies.
The NTP has published nearly 500
peer-reviewed technical reports on lifetime
bioassays for cancer (10). These reports are
used to alert the public to carcinogenic risks
posed by chemical agents in the environ-
ment, home, and workplace and in drugs
and pharmaceuticals. NTP technical reports
often provide the scientific information for
regulatory decision making by the EPA, the
Occupational Safety and Health Association
(OSHA), the FDA, the Consumer Product
Safety Commission, and many states.
Human exposuredata areneeded tointerpret
NTP toxicology data. For example, current
NTP studies quantify the amount ofchemi-
cal and/or active metabolites in blood and
target tissues associated with a given inci-
dence ofcancer in rodents. In future techni-
cal reports, we intend to quantify the
amount ofthat chemical in human blood as
a consequence of exposure circumstances
encountered in the home, general environ-
ment, or workplace, or through the pre-
scribed use of a pharmaceutical. This infor-
mation will help determine more accurately
the level ofpublichealth concern as a conse-
quenceofNTPtoxicologystudies.
The Center for the Evaluation ofRisks
to Human Reproduction, a center for the
assessment of human reproductive health
risks, will soon be established at the
NIEHS (11). The health issues addressed
will include adverse effects ofhuman expo-
sures on all aspects ofreproduction includ-
ing genetics, fertility, and development.
This activity is considered a priority
because ofthe need for timely, expert, and
balanced assessments ofreproductive health
hazards associated with human exposures
to environmental agents. Cases in the
recent past, such as the controversies sur-
rounding the reproductive effects ofAgent
Orange, the effects ofpesticide exposures
in children, and current concerns regarding
the GulfWarSyndrome and endocrine dis-
ruptors in the environment emphasize the
public interest in such an activity. The
assessments produced by the center will
have limited value without the indusion of
reliable exposure information.
The NTP also prepares the Report on
Carcinogens in response to section 301 (b)
(4) of the Public Health Service Act as
amended, which stipulates that the Secretary
of DHHS shall publish a report that con-
tains a list ofall substances 1) which either
are known to be human carcinogens, or may
reasonably be anticipated to be human car-
cinogens, and2) towhich asignificant num-
ber ofpersons residing in the United States
are exposed (12. The Secretary of DHHS
has delegated responsibility for preparation
of the report to the director ofthe NTP.
Thisdocument is usedbyregulatoryagencies
in priority setting and risk assessment. To
maximize use of the report in regulatory
decision making, exposure information
should accompany each chemical or sub-
stance listed. Such information would be
providedbythis exposure initiative.
Sensitive Subpopulations
Our current exposure database provides
strong evidence that body burdens of indi-
vidual chemicals vary tremendously across
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the U.S. population. The major determi-
nants of these variations are age, sex, work-
place exposures, lifestyle, diet, urban or rural
settings, accidental exposures, and social and
cultural inequities in environmental and
occupational exposures. Increase in body
burden can occur after a work shift or from
living or working near a contaminated site.
Elevated levels of perchloroethylene in air
have been found in apartments and in the
blood of persons living over or near dry
cleaning establishments (13,14). Dioxins
and PCBs in blood and adipose tissue
increase with age in the general population
and are sometimes elevated following occu-
pational exposure (15,16). However, the
same amount ofexposure may be associated
with much different body burdens. For
example, children often detoxifychemicals at
much different rates than adults, andwomen
often detoxify chemicals at different rates
than men (6). This exposure initiative will
provide the kind of data needed to deter-
mine which chemicals children are preferen-
tially exposed to so that actions can be taken
to minimize those exposures. Likewise, there
are numerous chemical-metabolizing genes
that are polymorphic, which cause some
people to be rapid metabolizers andothers to
be slow metabolizers. Therefore, some indi-
viduals retain some chemicals in their bodies
much longer than others. This exposure ini-
tiative will provide the focus necessary to
determine the true range of exposure that
occurs in U.S. populations and thereby
enable identification ofsensitive subpopula-
tions. Once identified, appropriate public





Gene/environment interactions are known
to be important for many diseases. For
example, allergies, asthma, cirrhosis, certain
cancers, other serious diseases, and risks for
adverse side efffects from pharmaceuticals
involve an interaction between genetic
makeup and the dose of chemicals to
which aperson is exposed (6).
The tools ofmolecular genetics provide
new opportunities to understand the genet-
ic basis for individual differences in suscep-
tibility to environmental exposure. The
NIEHS plans to expand its research pro-
gram on genetic susceptibility to environ-
mentally associated diseases through a new
Environmental Genome Project. This pro-
ject, which makes use oftechnology devel-
oped in the Human Genome Project, will
systematically identify the allelic variants of
environmental disease susceptibility genes
in the U.S. population, develop a central
database ofknown polymorphisms for these
genes, and foster population-based studies
ofgene/environment interaction in disease
etiology. By identifying those genes and
allelicvariants that affect individual response
to environmental toxins, we can better pre-
dict health risks and develop environmental
policies to protect the most vulnerable sub-
groups of the population. To meet this
objective, accurate exposure indices must
accompany thegenetic information (Fig. 2).
The NIEHS Environmental Genome
Project will be a broad, multicenter effort to
identify systematically in the U.S. popula-
tion the alleles of200 or more environmen-
tal disease susceptibility genes (5). A central
database ofthe polymorphisms will be made
available. This database will in turn support
both functional studies ofalleles and popu-
lation-based studies of disease risk. Such
population-based epidemiologic studies are
central to the identification ofboth the allel-
ic differences and the environmental expo-
sures that cause disease, and represent an
integral application of the Environmental
Genome Project.
Working with genetically susceptible
subgroups will allow us to identify more
precisely the environmental agents that
cause disease and the true risks ofexposure.
Results from the Environmental Genome
Project will lead to public health programs
1) for protecting susceptible populations,
2) for targeted screening ofgroups at high-
erriskofdisease, and 3) for more definitive
epidemiology studies including evaluation
in sensitive populations, provided that
credible exposure indices are available.
After all, if we wish to improve our
understanding of exposure/response rela-
tionships in sensitive subpopulations, we
musthave credible exposure data.
Risk Assessment
The recent flurry of activity and intense
controversy associated with health risk
assessment and its use in regulatory decisions
is generated bya numberofforces, induding
concerns ofindustry that costs ofcomplying
with environmental regulations are excessive,
concerns of environmentalists that risk
assessment practices and policies do not ade-
quately protect human and environmental
health, the public's lackofconfidence in reg-
ulatory decision making, and increasing
awareness that the scientific foundation for
manyriskassessments isweak (17).
Resolution ofthe controversy, develop-
ment ofeffective prevention strategies, and
rational priority setting can only be
achieved by strengthening the database
used to make regulatory decisions. A recent
estimate of federal expenditures for health
risk assessment-related research is $600
million/year (18); however, this figure is
probably greater than the actual dollars
spent. Although this seems to be a huge
sum, it is negligible in comparison to the
costs of the consequences of regulatory
decisions. The NIEHS and the CDC cur-
rently are collaborating on a pilot project
forquantifying approximately 70 chemicals
that are considered to be endocrine disrup-
tors in either human blood and urine (4).
This collaboration will strengthen the sci-
ence base for risk assessments in a number
ofways. For example, it will quantify the
amount of a given chemical or a chemical
structural class in the human body as a
consequence ofexposure from daily living.
Thus, this measurement can be considered
background exposure and directly com-
pared to the amount ofchemical needed to
produce adverse effects in experimental
Figure2 Functional linkage of exposure assessmenttothe study ofgene/environment interactions.
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models such as rats and mice. Ifthere is not
an adequate margin of safety, then public
health or worker protection could be
achieved by appropriate regulatory action.
The efficacy of those actions in reducing
human body burdens ofhazardous agents
could be evaluated bycontinuing to monitor
human body burdens after new regulations
are put into place. If there is an adequate
margin, additional regulatory actions may be
unnecessary. In the case of environmental
endocrine disruptors, we know that there are
scores ofenvironmental chemicals that pos-
sess hormonal activity, induding pesticides,
industrial by-products, health care products,
and those arising from the manufacture and
use ofplastics and detergents (19). In addi-
tion, there are numerous plant and fungal
products that also possess hormonal activity
and are known to produce health effects
when people are exposed to them in suffi-
cient quantities. Unfortunately, we know
very little about the human body burden of
these chemicals, and this lack ofknowledge
creates much of the controversy over their
impact onhuman health.
Human exposure assessment can also be
used in dose-response assessment and
extrapolation methodology. For example,
because the toxicityofagiven xenobiotic can
differ substantially between species, investi-
gators relying on animal data in risk assess-
ment are forced to assume that humans are
at least as susceptible as the most sensitive
animal species tested and to then use uncer-
tainty factors. However, interspecies differ-
ences are often mediated by differences in
metabolism, physiologic and anatomic dif-
ferences, and molecular receptor structure.
Use of the internal dose, or better yet the
biologically effective dose, accounts for the
toxicokinetic differences and thus allows for
better interspecies comparisons. This
decreases the need for uncertaintyfactors.
Accuracy of risk estimates can only be
improved by better scientific data and bet-
ter methods for incorporating such data
into the risk assessment process. Better
exposure assessment with body burden data
for general and exposed U.S. populations
will greatly improve the process.
Evaluation of Intervention
Strategies
The EPA and various state environmental
agencies are mandated to establish regula-
tions involving air and water standards and
cleanup of contaminated sites including
Superfund sites. Without body burden
measurements, it is not possible to deter-
mine how effective these regulations are.
The lower blood lead levels measured in
children by the CDC-NCEH following
EPA regullations mandating removal oflead
from gasoline was the most convincing
demonstration ofthe efficacy ofthis regula-
tion (20). In fact, the decreased blood lead
levels far exceeded expectations. Similar
measurement of body burden in children
playing in a Superfund site can demonstrate
whether or not elevated bodyburdens ofthe
chemical contaminants, such as lead or
volatile organics, exist. Ifthey do, appropri-
ate publichealth measures maybe indicated,
and follow-up blood measurements will be
able to determine efficacy ofaction taken. If
elevated body burdens do not exist at sites
where there is potential for exposure, costly
remediation measures may not be necessary.
Likewise, strategies for minimizing exposure
to chemicals in the workplace can be evalu-
ated and changes madewhen necessary.
Little ifany data exist on body burdens
for most chemicals of interest in the U.S.
general population and in groups potentially
exposed over time (21). Recent substantial
dedines in dioxin bodyburden ofEuropeans
have been reported. These decreases have
been attributed to new incinerator emission
regulations. It is not known whether the
same is true for the U.S. general population.
Other exposure circumstances of concern
include exposures that occur in the vicinity
of Superfund sites or in the workplace, or
those that arise from exposure to household
chemicals. Measurements of toxic chemicals
in workers' blood before and after actual or
potential exposure are essential to determine
whether there are increases in body burden
ofspecific chemicals such as perchloroethyl-
ene, benzene, or chloroform. Outdated body
burden measurements can lead to misleading
interpretations of risks. For example, blood
PCB levels in the general U.S. adult popula-
tion are currently lower than in the recent
past (22). Without this kind ofknowledge,
risk assessments, epidemiology studies, and
individual medical decisions would be based
onoutdated information.
Mixtures
Credible experimental strategies on mix-
tures is either limited or nonexistent, yet
mixture studies are the most relevant
because people are exposed to chemicals as
mixtures in the environment and in the
workplace, not as single chemicals. The
problem in designing mixture studies stems,
in part, from our lack of knowledge con-
cerning the characterization ofreal-life mix-
tures based on human exposure or human
body burden. The exposure initiative will
provide the kind of information necessary
for constructing real-life mixtures. These
mixtures will then be used in a variety of
experimental situations: in vztro, rodent tox-
icology, and computational analysis (i.e.,
predictions of chemical interactions with
cellular macromolecules such as receptors).
In the case ofenvironmental estrogens, we
will have the information necessary to
develop approaches fordetermining ifinter-
actions result in synergy or antagonism, or
neither, and thereby resolve much of the
controversy over whether or not weak envi-
ronmental estrogens act synergistically and
pose a serious human health threat. Of
course, the problem with mixtures extends
far beyond the endocrine disruptor issue.
We know that particulates and volatile air
toxics can interact to substantially increase
lung cancer risks. Likewise, risk of radon-
induced lung cancer is increased in cigarette
smokers, and hepatitis B infection increases
chemically-induced livercancer (23,24).
Broad-based knowledge on the quantities
ofdifferent chemicals in people's bodies will
facilitate the evolution ofmixture research to
take advantage ofthe tools ofmolecular toxi-
cology. Forexample, afirst step in usingreal-
life mixtures could be to test them in high-
throughput molecular screens to determine if
mixtures are causing changes in gene expres-
sion or other early critical events in toxicity.
It will also be possible, using such approach-
es, to evaluate whether the mixture is modi-
fying the toxicity ofindividual components
ofthat mixture (i.e., increased DNAdamage
from polycyclic aromatic hydrocarbons).
Results from the molecular screens would be
used to set priorities for further research
including moretime-consuming animal toxi-
cology and/or molecular epidemiologic stud-
ies. This approach ensures that valuable
resources are not wasted on the study oflow
prioritymixtures.
In summary, the exposure assessment
initiative is needed to address public health
issues and to enhance the NTP's ability to
meet its public health goals. It is feasible
because of recent advances in analytical
technology and molecular biology, and it is
an example of how different agencies can
work together to address environmental
health concerns.
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